Education
About Us
Working with TipRanks
Follow Us
PureTech Health (PRTC)
NASDAQ:PRTC
Total Valuation
PureTech Health has a market cap or net worth of $432.90M. The enterprise value is $106.53M.
Market Cap$432.90M
Enterprise Value$106.53M
Share Statistics
PureTech Health has 24,168,404 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,168,404
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PureTech Health’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is -27.95%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)-27.95%
Return on Capital Employed (ROCE)-0.24
Revenue Per Employee60.35K
Profits Per Employee347.27K
Employee Count80
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PureTech Health is 9.9. PureTech Health’s PEG ratio is -0.05.
PE Ratio9.9
PS Ratio103.10
PB Ratio1.20
Price to Fair Value1.20
Price to FCF-3.70
Price to Operating Cash Flow-4.41
PEG Ratio-0.05
Income Statement
In the last 12 months, PureTech Health had revenue of 4.83M and earned 53.51M in profits. Earnings per share was 2.00.
Revenue4.83M
Gross Profit1.26M
Operating Income-136.09M
Pretax Income23.77M
Net Income53.51M
EBITDA37.38M
Earnings Per Share (EPS)2.00
Cash Flow
In the last 12 months, operating cash flow was -100.30M and capital expenditures -11.00K, giving a free cash flow of -100.31M billion.
Operating Cash Flow-100.30M
Free Cash Flow-100.31M
Free Cash Flow per Share-4.15
Dividends & Yields
PureTech Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.55
52-Week Price Change-9.73%
50-Day Moving Average17.42
200-Day Moving Average17.85
Relative Strength Index (RSI)52.62
Average Volume (3m)4.19K
Important Dates
PureTech Health upcoming earnings date is Apr 23, 2026, TBA (Confirmed).
Last Earnings DateAug 28, 2025
Next Earnings DateApr 23, 2026
Ex-Dividend Date―
Financial Position
PureTech Health as a current ratio of 9.33, with Debt / Equity ratio of 5.56%
Current Ratio9.33
Quick Ratio9.33
Debt to Market Cap<0.01
Net Debt to EBITDA-6.91
Interest Coverage Ratio-13.56
Taxes
In the past 12 months, PureTech Health has paid -4.01M in taxes.
Income Tax-4.01M
Effective Tax Rate-0.17
Enterprise Valuation
PureTech Health EV to EBITDA ratio is 6.41, with an EV/FCF ratio of -1.78.
EV to Sales49.61
EV to EBITDA6.41
EV to Free Cash Flow-1.78
EV to Operating Cash Flow-1.78
Balance Sheet
PureTech Health has $321.55M in cash and marketable securities with $20.92M in debt, giving a net cash position of $300.63M billion.
Cash & Marketable Securities$321.55M
Total Debt$20.92M
Net Cash$300.63M
Net Cash Per Share$12.44
Tangible Book Value Per Share$15.11
Margins
Gross margin is 338.65%, with operating margin of -2818.87%, and net profit margin of 1108.33%.
Gross Margin338.65%
Operating Margin-2818.87%
Pretax Margin492.42%
Net Profit Margin1108.33%
EBITDA Margin774.28%
EBIT Margin700.31%
Analyst Forecast
The average price target for PureTech Health is $46.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$46.00
Price Target Upside155.56% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast1268.81%
EPS Growth Forecast―